AI assistant
Sending…
Lufax Holding Ltd — Director's Dealing 2024
Oct 22, 2024
51012_rns_2024-10-22_97d93ab5-5644-49fb-bcf7-513c4f84310e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
22 October 2024
Mandatory general offer
Disclosure of dealings in the shares of Lufax Holding Ltd
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Description of relevant securities |
Nature of dealings | Purchase / Sale |
Total number of shares involved |
Total amount paid / received (USD) |
Highest (H) prices paid / received (USD) |
Lowest (L) prices paid / received (USD) |
|---|---|---|---|---|---|---|---|---|
| UBS AG | 18 October 2024 |
Ordinary shares |
Dealing in a derivative which is referenced to a basket or index including relevant securities which represent less than 1% of the class in issue and less than 20% of the value of the securities in the basket or index |
Purchase | 349 | $1,102.8400 | $3.1600 | $3.1600 |
| Ordinary shares |
Dealing in a derivative which is referenced to a basket or index including relevant securities which represent less than 1% of the class in issue and less than 20% of the value of the securities in the basket or index |
Sale | 3,861 | $12,298.6500 | $3.2000 | $3.1600 |
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
End
Note:
UBS AG is an exempt principal trader connected with the Offeree company.
Dealings were made for its own account.
These were dealings in ADS of the Offeree Company. Dealings were made in USD. Each ADS represents 2 ordinary shares in the Offeree Company. UBS AG is ultimately owned by UBS Group AG.
More from Lufax Holding Ltd
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 30
Annual Report
2026
Apr 30
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27